Cryosite ceased collection and storage of new cord blood/tissue samples in 2017. We’re committed to preserving cord storage for samples collected and processed by Cryosite before this period.
A baby’s umbilical cord contains blood and tissue, which are rich sources of therapeutic stem cells.
Stem cells are special because they can divide and make exact copies of themselves and develop into other specific cell types, tissues or organs in the body. Cord blood and cord tissue are used as sources of different types of stem cells.
Cord blood/tissue samples are a unique 100% match to the individual from whom they are collected and cannot be replaced.
Samples may provide future treatment options for immediate family members; parents have a partial match and siblings have a potential match.
Cord blood banking helps our clients safeguard their families' future health outcomes by storing cord blood and tissues, ensuring they take an important step in protecting their loved ones.
Cord blood is a source of haematopoietic stem cells, which can produce blood cells that carry oxygen, fight infection and stop bleeding.
A cord blood sample, gathered at birth, offers greatly increased options and benefits in the treatment of over 80 diseases—including leukemias, blood diseases and lymphomas—compared to synthetic or donated stem cells.
Cord tissue contains several cell types that can produce many different types of cells including bone, cartilage, muscle.
Current research explores bone conditions, heart disease, graft-versus-host disease in donor marrow transplantation, and autoimmune responses in multiple sclerosis and systemic lupus erythematosus. Cord blood banking offers hope for these advancements, potentially transforming treatment options and patient outcomes.
Over 1000 clinical trials around the world are currently recruiting patients to investigate the further potential of stem cell transplants and future use in regenerative medicine.
New technology will also allow development of stored stem cells to the next generation of advanced cell therapies and personalised treatment.
Stem Cells Australia has an interesting summary of current Australian Stem Cell Research projects.
While the potential of stem cell therapies is exciting, it is important to note that current approved uses are limited, results are variable and future uses are developing in clinical trials. The decision to use stem cells should be made with a cellular therapy professional.
A baby’s umbilical cord contains blood and tissue, which are rich sources of therapeutic stem cells.
Stem cells are special because they can divide and make exact copies of themselves and develop into other specific cell types, tissues or organs in the body. Cord blood and cord tissue are used as sources of different types of stem cells.
Cord blood/tissue samples are a unique 100% match to the individual from whom they are collected and cannot be replaced.
Samples may provide future treatment options for immediate family members; parents have a partial match and siblings have a potential match.
Cord blood banking helps our clients safeguard their families' future health outcomes by storing cord blood and tissues, ensuring they take an important step in protecting their loved ones.
Cord blood is a source of haematopoietic stem cells, which can produce blood cells that carry oxygen, fight infection and stop bleeding.
A cord blood sample, gathered at birth, offers greatly increased options and benefits in the treatment of over 80 diseases—including leukemias, blood diseases and lymphomas—compared to synthetic or donated stem cells.
Cord tissue contains several cell types that can produce many different types of cells including bone, cartilage, muscle.
Current research explores bone conditions, heart disease, graft-versus-host disease in donor marrow transplantation, and autoimmune responses in multiple sclerosis and systemic lupus erythematosus. Cord blood banking offers hope for these advancements, potentially transforming treatment options and patient outcomes.
Over 1000 clinical trials around the world are currently recruiting patients to investigate the further potential of stem cell transplants and future use in regenerative medicine.
New technology will also allow development of stored stem cells to the next generation of advanced cell therapies and personalised treatment.
Stem Cells Australia has an interesting summary of current Australian Stem Cell Research projects.
While the potential of stem cell therapies is exciting, it is important to note that current approved uses are limited, results are variable and future uses are developing in clinical trials. The decision to use stem cells should be made with a cellular therapy professional.
Cryosite ensures top-notch umbilical cord blood storage in a secure facility with cutting-edge equipment for peace of mind.
Take a virtual tour of our laboratory.
